SSII
SS Innovations International, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.41
+0.59%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−108.4x
Market Cap
$683.31M
MomentumView details →
1D Return
+0.59%
YTD Return
−39.96%
RSI (14)
41.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−108.4x
Market Cap
$683.31M
RSI (14)
41.1
MomentumView details →
1D Return
+0.59%
YTD Return
−39.96%
SummaryUpdated Jun 1, 2026
SS Innovations International, Inc. (NASDAQ:SSII) is a medical device company founded in India that went public on the NASDAQ in October 2018. The company is headquartered in Fort Lauderdale, Florida, and specializes in developing surgical robotic systems primarily for minimally invasive procedures. SS Innovations represents one of the emerging players in the global surgical robotics market, competing against established giants like Intuitive Surgical's da Vinci system. The company has been working to commercialize its robotic surgical platforms while building manufacturing capabilities and expanding its market presence internationally.
Similar companies
Latest newsMore news →
Sarah Romano departed as Chief Financial Officer of SS Innovations International, Inc. on August 21, 2026.10d agoKings Hospital launched its robotic surgery programme using India's SSI Mantra Surgical Robotic System, with the first robot-assisted cholecystectomy performed in Sri Lanka.12d agoSS Innovations reported its second quarter 2026 financial results, with record quarterly revenue driven by strong growth in SSi Mantra unit sales.22d ago